EASD 2026: GLP-1 and SGLT2 treatment lowers mortality in heart failure patients
At EASD 2026, retrospective research was presented that showed initial correlations between the use of SGLT2 inhibitors and GLP-1 agonists in diabetic patients undergoing treatment for acute heart failure in the hospital setting.
